11.36
前日終値:
$10.93
開ける:
$10.9
24時間の取引高:
1.06M
Relative Volume:
1.86
時価総額:
$486.41M
収益:
$159.01M
当期純損益:
$-21.72M
株価収益率:
-21.85
EPS:
-0.52
ネットキャッシュフロー:
$-20.63M
1週間 パフォーマンス:
+4.70%
1か月 パフォーマンス:
+4.03%
6か月 パフォーマンス:
-22.72%
1年 パフォーマンス:
+50.66%
Axogen Inc Stock (AXGN) Company Profile
AXGN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
AXGN
Axogen Inc
|
11.36 | 486.41M | 159.01M | -21.72M | -20.63M | -0.52 |
![]()
ABT
Abbott Laboratories
|
133.70 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
103.83 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
392.51 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.67 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
76.69 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-17 | 開始されました | Lake Street | Buy |
2024-07-01 | 開始されました | Raymond James | Outperform |
2022-11-11 | 再開されました | Jefferies | Buy |
2022-05-09 | アップグレード | Canaccord Genuity | Hold → Buy |
2022-03-11 | 再開されました | Cantor Fitzgerald | Overweight |
2020-10-23 | 開始されました | Guggenheim | Buy |
2020-06-16 | 再開されました | Cantor Fitzgerald | Overweight |
2020-05-07 | ダウングレード | Canaccord Genuity | Buy → Hold |
2020-04-02 | ダウングレード | BTIG Research | Buy → Neutral |
2019-08-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
2019-07-12 | 開始されました | Canaccord Genuity | Buy |
2018-03-02 | 繰り返されました | Lake Street | Buy |
2018-01-05 | 再開されました | Cantor Fitzgerald | Overweight |
2017-11-30 | 開始されました | Jefferies | Buy |
2017-11-21 | 繰り返されました | Lake Street | Buy |
2017-07-31 | 開始されました | Leerink Partners | Outperform |
2017-06-30 | 開始されました | Cantor Fitzgerald | Overweight |
2017-03-06 | 開始されました | ROTH Capital | Buy |
2016-11-22 | アップグレード | Lake Street | Hold → Buy |
2016-11-07 | 繰り返されました | Wedbush | Outperform |
2016-11-03 | ダウングレード | Lake Street | Buy → Hold |
2016-08-04 | 繰り返されました | Wedbush | Outperform |
2014-05-14 | 開始されました | Dawson James | Buy |
2013-10-31 | 繰り返されました | Ladenburg Thalmann | Buy |
すべてを表示
Axogen Inc (AXGN) 最新ニュース
Institutional investors in Axogen, Inc. (NASDAQ:AXGN) see US$53m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
AxoGen at Goldman Sachs Conference: Strategic Path to Nerve Repair Growth - Investing.com Canada
Transcript : Axogen, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 02 - MarketScreener
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results - The Globe and Mail
AxoGen, Inc. (NASDAQ:AXGN) Sees Significant Increase in Short Interest - Defense World
AxoGen FY2025 EPS Estimate Decreased by Cantor Fitzgerald - Defense World
Axogen Inc (AXGN) Trading Down 3.17% on Jun 4 - GuruFocus
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In AxoGen, Inc. To Contact The Firm - ACCESS Newswire
AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Nuveen Asset Management LLC - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Receives $22.20 Average Price Target from Analysts - Defense World
Millennium Management LLC Lowers Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
ProShare Advisors LLC Invests $197,000 in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
BNP Paribas Financial Markets Has $102,000 Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Jane Street Group LLC Sells 30,670 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference - GlobeNewswire
Bank of America Corp DE Reduces Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Nigeria
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth - Investing.com Australia
Ameriprise Financial Inc. Has $4.81 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Insider Sell: Joseph Tyndall Sells 2,525 Shares of Axogen Inc (A - GuruFocus
Nerve Regeneration Market Deep Research Report with Forecast - openPR.com
AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
How To Trade (AXGN) - news.stocktradersdaily.com
Northern Trust Corp Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
The Manufacturers Life Insurance Company Sells 1,016 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Study Evaluating AxoGen Nerve Graft Complete - Medical Product Outsourcing
Canaccord Genuity Group Has Lowered Expectations for AxoGen (NASDAQ:AXGN) Stock Price - Defense World
Tower Research Capital LLC TRC Sells 1,087 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Nerve Wrap Market Size & Share | Industry Report, 2030 - Grand View Research
Cantor Fitzgerald Reduces Earnings Estimates for AxoGen - Defense World
Axogen (AXGN) Sees Price Target Reduction by Canaccord Genuity | - GuruFocus
Canaccord Adjusts AxoGen (AXGN) Price Target Following Q1 Updates | AXGN Stock News - GuruFocus
What Analysts Are Saying About Axogen Stock - Benzinga
Canaccord Adjusts AxoGen (AXGN) Price Target Following Q1 Update - GuruFocus
Price T Rowe Associates Inc. MD Has $574,000 Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen stock target cut to $24 by Canaccord Genuity - Investing.com South Africa
AxoGen, Inc. (NASDAQ:AXGN) Q1 2025 Earnings Call Transcript - Insider Monkey
(AXGN) Long Term Investment Analysis - news.stocktradersdaily.com
Axogen, Inc. (NASDAQ:AXGN) Might Not Be As Mispriced As It Looks After Plunging 32% - simplywall.st
Axogen, Inc.'s (NASDAQ:AXGN) Intrinsic Value Is Potentially 87% Above Its Share Price - Yahoo Finance
Dimensional Fund Advisors LP Raises Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen’s Earnings Call: Growth Amid Challenges - TipRanks
Breakeven On The Horizon For Axogen, Inc. (NASDAQ:AXGN) - simplywall.st
Balance Sheet Insights: Axogen Inc (AXGN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Axogen, Inc. Reports 2025 First Quarter Financial Results - GlobeNewswire
Axogen Inc (AXGN) 財務データ
収益
当期純利益
現金流量
EPS
Axogen Inc (AXGN) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Levine Alan M | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
36,743 |
Wendell Amy McBride | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
93,826 |
Burke William P. Mr. | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,484 |
NEELS GUIDO J | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
86,743 |
JOHNSON JOHN | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,943 |
TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Option Exercise |
6.56 |
11,586 |
75,952 |
26,931 |
TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Sale |
10.72 |
26,931 |
288,700 |
0 |
大文字化:
|
ボリューム (24 時間):